Perimenopause Blood Tests: What They Can and Can't Tell You

Usually, no — not on its own. For women over 45 with typical symptoms and changing periods, major medical bodies including The Menopause Society (formerly NAMS) and the UK's NICE guidelines recommend diagnosing perimenopause clinically, based on your symptoms and menstrual pattern, without routine hormone blood tests. This surprises many women who expect a definitive lab result, but the biology explains it.

During perimenopause, your ovaries do not simply 'run down' in a smooth line. Instead, hormone levels fluctuate dramatically from day to day and even hour to hour. Estrogen can spike high one week and drop low the next. Because a blood test captures only a single moment, a 'normal' result today does not rule out perimenopause, and an 'abnormal' one tomorrow does not confirm it. You could test the same woman twice in a month and get contradictory numbers.

That is why your symptom pattern — hot flashes, sleep changes, irregular cycles, mood shifts, brain fog — is the most reliable signal. If you are noticing these changes, it helps to know what to look for; our guides on the [early signs of perimenopause](/blog/early-signs-of-perimenopause-what-to-watch-for) and the full [34 symptoms of perimenopause](/blog/34-symptoms-of-perimenopause-complete-checklist) can help you recognize the pattern and describe it clearly to your clinician.

FSH (follicle-stimulating hormone) is the test most people have heard of, but it is widely misunderstood. FSH is produced by your pituitary gland to stimulate the ovaries. As the ovaries become less responsive with age, the pituitary pumps out more FSH to compensate, so FSH tends to rise as you approach menopause. A consistently high FSH (often cited above 30 mIU/mL) alongside no periods for 12 months supports a diagnosis of menopause.

The problem is perimenopause, the years *before* that point. During this transition, FSH bounces up and down along with your fluctuating estrogen. You can have a high FSH one month and a completely normal one the next while still being firmly in perimenopause. This is exactly why the landmark SWAN study (Study of Women's Health Across the Nation), which has followed thousands of women through the transition since 1994, showed how variable these hormones are across the menopause journey.

FSH testing becomes genuinely useful in specific situations: in women under 45 where premature or early menopause is suspected, in women who have had a hysterectomy (and so cannot track periods), or in those on certain hormonal contraceptives where cycle tracking is masked. Outside those cases, a single FSH result rarely changes what your symptoms are already telling you.

Estradiol is the main form of estrogen your ovaries produce, and like FSH it swings unpredictably during perimenopause. It does not fall in a tidy downward slope; it can surge and crash. A single estradiol reading is therefore a poor way to diagnose the transition. Estradiol is more useful for a different job — for example, checking levels when you are on hormone therapy to see whether a dose is being absorbed, rather than for diagnosis.

AMH (anti-Müllerian hormone) has gained popularity because it reflects your ovarian reserve — roughly, how many eggs remain. AMH declines steadily with age and becomes very low near menopause, and researchers are studying whether it can help *predict* the timing of the final period. But AMH does not diagnose perimenopause, does not predict your symptoms, and is not needed for most women to understand where they are. It is most relevant in fertility planning and in evaluating suspected early menopause.

The practical takeaway: no single hormone panel neatly captures perimenopause, because the whole hallmark of this phase is variability. Numbers can inform the picture, especially in younger women, but they rarely replace a careful look at your symptoms and cycle history. If you are weighing treatment options, understanding [when to start HRT and the timing hypothesis](/blog/when-to-start-hrt-the-timing-hypothesis-explained) is often more useful than chasing lab values.

Blood tests earn their place mainly for ruling other things out, not for confirming perimenopause. Many perimenopause symptoms overlap with other treatable conditions, and testing helps make sure you are not missing something else. The most valuable test is often a thyroid panel (TSH), because an underactive or overactive thyroid can cause fatigue, weight changes, mood shifts, irregular periods, and temperature intolerance that mimic perimenopause almost exactly.

Other bloodwork your clinician may consider includes a complete blood count (to check for anemia, especially if heavy perimenopausal bleeding is an issue), ferritin (iron stores), vitamin D, blood sugar, and a lipid panel — the latter because cholesterol often shifts unfavorably as estrogen declines, a change worth catching early. Our article on [menopause and cholesterol changes](/blog/menopause-cholesterol-changes-why-ldl-rises-and-what-helps) explains why LDL tends to rise in this window.

Blood tests are also clearly warranted when symptoms appear before age 45, when menopause is suspected under 40 (primary ovarian insufficiency), after certain surgeries, or when something in your history does not fit the usual pattern. The bottom line: if a test will actually change your diagnosis or treatment, it is worth doing. If it will only give you a snapshot of a hormone that is bouncing around anyway, your symptoms remain the better guide. Perimenopause symptoms are also frequently mistaken for other things entirely — our piece on [perimenopause and ADHD](/blog/perimenopause-and-adhd-why-symptoms-get-missed) shows how easily the transition gets misread.